Who is sponsoring NCT05363553?

NCT05363553 is sponsored by Dairy Goat Co-operative (N.Z.) Limited.

What drugs are being tested in NCT05363553?

Interventions in NCT05363553: Infant formula based on whole goat milk, infant formula based on cow milk proteins.

What condition does NCT05363553 study?

NCT05363553 studies Gastrointestinal Disorder, Functional, Regurgitation, Gastric, Colic, Infantile, Constipation - Functional, Infant Development.

Is NCT05363553 still recruiting?

NCT05363553 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT05363553: TIGER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study

Completed NA Last updated 19 September 2024

What this trial tests

NA trial testing Infant formula based on whole goat milk in Gastrointestinal Disorder, Functional in 146 participants. Completed in 28 August 2024.

Timeline

25 May 2022

Primary endpoint
30 April 2024

28 August 2024

Quick facts

Lead sponsor	Dairy Goat Co-operative (N.Z.) Limited
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	146
Start date	25 May 2022
Primary completion	30 April 2024
Estimated completion	28 August 2024
Sites	1 location across Thailand

Drugs / interventions tested

Infant formula based on whole goat milk
infant formula based on cow milk proteins

Conditions studied

Gastrointestinal Disorder, Functional — all drugs for Gastrointestinal Disorder, Functional →
Regurgitation, Gastric — all drugs for Regurgitation, Gastric →
Colic, Infantile — all drugs for Colic, Infantile →
Constipation - Functional — all drugs for Constipation - Functional →

Sponsor

Dairy Goat Co-operative (N.Z.) Limited

Who can join

Adults 2 Weeks to 4 Months, any sex, with Gastrointestinal Disorder, Functional or Regurgitation, Gastric. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the frequency of regurgitation and other digestive outcomes between infants who receive an infant formula based on whole goat milk and an infant formula based on cow milk proteins during the transition period from breastfeeding to formula feeding, using predominantly breastfed infants as a reference group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Goat-Milk-Based Infant Formulas on Growth and Safety Parameters: A Systematic Review and Meta-Analysis.
Jankiewicz M, van Lee L, Biesheuvel M, Brouwer-Brolsma EM, et al · · 2023 · cited 8× · PMID 37432055 · DOI 10.3390/nu15092110

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05363553 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dairy Goat Co-operative (N.Z.) Limited
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05363553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing